FAPi PET/CT Imaging to Identify Fibrosis in Immune-Mediated Inflammatory Diseases

FAPi PET/CT Imaging to Identify Fibrosis in Immune-Mediated Inflammatory Diseases

Immune-mediated inflammatory diseases (IMIDs) are characterized by chronic systemic inflammation and multi-organ involvement. Fibrosis formation in IMIDs can cause tissue destruction and subsequently organ malfunction. Fibroblast activation protein inhibitor positron emission tomography/computed tom...

Full description

Saved in:

Bibliographic Details
Main Authors:	Dalia A. Lartey, Lynn A. Schilder, Gerben J. C. Zwezerijnen, Geert R. A. M. D’Haens, Joep Grootjans, Mark Löwenberg
Format:	Article
Language:	English
Published:	MDPI AG 2025-03-01
Series:	Biomedicines
Subjects:	fibrosis immune-mediated inflammatory diseases (IMIDs) FAPi PET/CT fibroblast activation protein (FAP) positron emission tomography imaging
Online Access:	https://www.mdpi.com/2227-9059/13/4/775
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Preclinical evaluation of [68Ga]Ga-AAZTA-FAPI-46: a novel PET tracer for targeting fibroblast activation protein (FAP)
by: Rebecca Rizzo, et al.
Published: (2025-08-01)

Molecular Imaging of Fibroblast Activation Protein in Response to Cardiac Injury Using [<sup>68</sup>Ga]Ga-DATA<sup>5m</sup>.SA.FAPi
by: Victoria Weissenböck, et al.
Published: (2025-04-01)

Comparison of [18F]AlF-NOTA-FAPI-04 PET/CT and [18F]FDG PET/CT for diagnosing lymph node metastasis in malignant tumors
by: Wanjing Zhou, et al.
Published: (2025-07-01)

FAPI-PET/CT guided radiotherapy for patients with esophageal cancer
by: Kai Kröger, et al.
Published: (2025-02-01)

Aged‐Related Fibroblast Activation Protein Expression in Skeletal Muscles Evaluated by PET Imaging
by: Minseok Suh, et al.
Published: (2025-02-01)

Comparative Imaging Analysis of Kimura&rsquo;s Disease Using 18F-FDG PET/CT and [18F]AlF-NOTA-FAPI-04 PET/CT
by: Sun C, et al.
Published: (2025-05-01)

The role of FAPI PET/CT in patients with lymphoma: a systematic review
by: Natale Quartuccio, et al.
Published: (2025-05-01)

Characteristics of 18F-FAPI-04 PET/CT in patients with peritoneal metastasis and to predict treatment efficacy, a head-to-head comparison with 18F-FDG PET/CT
by: Yafei Zhang, et al.
Published: (2025-06-01)

PET/CT WITH 68GA-FAPI46 FOR THE DETECTION OF PRIMARY AND METASTATIC LESIONS IN PATIENTS WITH DIFFERENT TYPES OF CANCER. INITIAL EXPERIENCE
by: Lilian Yuri Itaya Yamaga, et al.
Published: (2025-05-01)

Evaluation of myocardial fibrosis and wall motion abnormality with 68Ga-FAPI PET/MR in coronary heart disease
by: Rui Luo, et al.
Published: (2025-07-01)

Fibroblast Activation Protein Inhibitor (FAPI)-Based Theranostics
by: William Serumula, et al.
Published: (2025-04-01)

Preliminary evaluation of FAPI-04-PET/CT for differentiating recurrence and post-treatment changes in high-grade gliomas
by: Indraja D. Dev, et al.
Published: (2024-10-01)

18F‐FAPI versus 18F‐FDG PET/CT in the Diagnosis of Relapsing Polychondritis
by: Xiaotong Guo, et al.
Published: (2024-12-01)

Detection of gastric cancer with implantation metastasis to the inguinal region via 18F-FAPI PET/CT: a case report
by: Haibo Zhang, et al.
Published: (2025-07-01)

Enhanced contrast in FAP-targeting PET imaging with 61Cu-labeled FAP inhibitors: development and preclinical evaluation of novel [61Cu]Cu-Kalios PET radioligands
by: Jacopo Millul, et al.
Published: (2025-08-01)

Comparison of Al[18F]-NOTA-FAPI-04 PET/CT and [18F]-FDG PET/CT in a patient with lung cancer and pulmonary tuberculosis: a case report and literature review
by: Jingjie Qin, et al.
Published: (2025-02-01)

Emerging PET-radiotracers in cardiovascular, neuro-inflammation, lung and rheumatological diseases: a narrative review
by: Domenico Albano, et al.
Published: (2025-08-01)

Based on small molecules: development and application of fibroblast activation protein inhibitors radiopharmaceutical in tumor precision therapy
by: Yihui Luo, et al.
Published: (2025-05-01)

[68Ga]Ga-FAPI-46 PET/CT for Staging Suspected/Confirmed Lung Cancer: Results on the Surgical Cohort Within a Monocentric Prospective Trial
by: Lucia Zanoni, et al.
Published: (2024-11-01)

Comparison of 68Ga-FAPI-04 PET/CT with CECT in the evaluation of peritoneal metastases from gastrointestinal cancers and impact on clinical decision-making
by: Yushan Zhou, et al.
Published: (2025-07-01)

Cutting the Gordian Knot: Rare Presentation of Nodular Fasciitis as Supraclavicular Swelling with Muscular Involvement in <sup>68</sup>Ga-FAPI-PET/CT
by: Lukas A. Brust, et al.
Published: (2024-10-01)

68Ga-FAPI PET/CT for diagnostic accuracy and therapeutic response assessment in bleomycin-induced pulmonary fibrosis: an integrated preclinical study
by: Rui Sun, et al.
Published: (2025-06-01)

Revolutionizing cancer diagnosis and dose biodistribution: a meta-analysis of [68ga] FAPI- 46 vs. [18f] FDG imaging
by: Samaneh Abbasi, et al.
Published: (2025-05-01)

Recent Updates of PET in Lymphoma: FDG and Beyond
by: Sung-Yong Kim, et al.
Published: (2024-10-01)

Comparison of [99mTc]Tc-FAPI SPECT/CT and [18F]FDG PET/CT as predictive biomarkers for immunotherapy response in gastrointestinal cancer
by: Yu Zhang, et al.
Published: (2025-05-01)

Diagnostic performance of [68Ga]Ga-FAPI-04 PET vs. [18F]FDG PET in detecting lymph node metastasis in digestive system cancers: a head-to-head comparative meta-analysis
by: Huo Li, et al.
Published: (2025-03-01)

Impact of 68Ga-FAPI positron emission tomography/computed tomography on staging and tumor management in patients with gastric cancer
by: Shunyu Zhang, et al.
Published: (2025-01-01)

Detecting radiation esophagitis using 18F-FAPI-04 PET/CT in patients with LA-ESCC treated with concurrent chemoradiotherapy
by: Xinying Hu, et al.
Published: (2025-05-01)

Quantitative Assessment of Baseline Serum HDL-C to Predict Gout Flares During Urate-Lowering Therapy Initiation: A Prospective Cohort Study [Corrigendum]
by: Jiang C, et al.
Published: (2025-05-01)

A heterodimeric radioligand labeled with gallium-68 targeting fibroblast activation protein
by: Chengde Xie, et al.
Published: (2025-05-01)

Fibroblast activation protein inhibitor (FAPI)-negative huge renal cell carcinoma demonstrating an intriguing pattern on [99mTc]Tc-FAPI-46 scintigraphy
by: Nasrin Raeisi, et al.
Published: (2025-08-01)

Fibroblast Activation Protein Acts as a Biomarker for Monitoring ECM Remodeling During Aortic Aneurysm via 68Ga‐FAPI‐04 PET Imaging
by: Chengkai Hu, et al.
Published: (2025-04-01)

Circulating soluble fibroblast activation protein (FAP) in patients with intra-thoracic cancer undergoing chest radiation
by: Tim Lange, et al.
Published: (2025-07-01)

Brown adipose tissue activity on PET/CT and the course of Hodgkin lymphoma
by: Taner Tan, et al.
Published: (2025-02-01)

Added value of dual-phase 99mTc-HYNIC-FAPI-04 SPECT/CT in postoperative follow-up of colorectal cancer
by: Donghua Sun, et al.
Published: (2025-06-01)

Targeting fibroblast activation protein in rheumatoid arthritis: from molecular imaging to precision therapeutics
by: Yupeng Huang, et al.
Published: (2025-06-01)

Fibroblast activation protein and the tumour microenvironment: challenges and therapeutic opportunities
by: Hsing Hwa Lee, et al.
Published: (2025-07-01)

Novel Molecular Classification of Breast Cancer with PET Imaging
by: Ngô Minh Toàn
Published: (2024-12-01)

Targeting neuroinflammation: 3-monothiopomalidomide a new drug candidate to mitigate traumatic brain injury and neurodegeneration
by: Shih Chang Hsueh, et al.
Published: (2025-06-01)

Comparative study of total-body PET and PET/MR in the diagnosis of liver metastases
by: Cao Junxia, et al.
Published: (2025-05-01)